Advertisement

Index by author

November 01, 1985; Volume 13,Issue 6

B

  1. Billing, B

    1. Comparison of theophylline and theobromine metabolism in man.
      D J Birkett, R Dahlqvist, J O Miners, A Lelo and B Billing
      Drug Metabolism and Disposition November 1985, 13 (6) 725-728;

  2. Birkett, D J

    1. Comparison of theophylline and theobromine metabolism in man.
      D J Birkett, R Dahlqvist, J O Miners, A Lelo and B Billing
      Drug Metabolism and Disposition November 1985, 13 (6) 725-728;

  3. Bowman, E R

    1. In vivo mammalian metabolism of methylamine and methylurea and their metabolic interrelationship.
      M S Dar and E R Bowman
      Drug Metabolism and Disposition November 1985, 13 (6) 682-689;

  4. Breeze, R G

    1. Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate.
      M R Nocerini, G S Yost, J R Carlson, D J Liberato and R G Breeze
      Drug Metabolism and Disposition November 1985, 13 (6) 690-694;

  5. Butler, E G

    1. Paraoxon hydrolysis vs. covalent binding in the elimination of paraoxon in the rabbit.
      E G Butler, H W Eckerson and B N La Du
      Drug Metabolism and Disposition November 1985, 13 (6) 640-645;

C

  1. Campbell, P

    1. In vitro digitoxin metabolism. Rate-limiting step and alteration following spironolactone pretreatment.
      W C Kershaw, P Campbell and G L Lage
      Drug Metabolism and Disposition November 1985, 13 (6) 635-639;

  2. Carlson, J R

    1. Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate.
      M R Nocerini, G S Yost, J R Carlson, D J Liberato and R G Breeze
      Drug Metabolism and Disposition November 1985, 13 (6) 690-694;

  3. Chism, J P

    1. Isomer- and sex-specific bioactivation of mononitrotoluenes. Role of enterohepatic circulation.
      J P Chism and D E Rickert
      Drug Metabolism and Disposition November 1985, 13 (6) 651-657;

  4. Coffman, B L

    1. Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
      L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
      Drug Metabolism and Disposition November 1985, 13 (6) 700-704;

  5. Cossum, P A

    1. Metabolism of dinitrobenzenes by rat isolated hepatocytes.
      P A Cossum and D E Rickert
      Drug Metabolism and Disposition November 1985, 13 (6) 664-668;

  6. Crooks, P A

    1. In vitro characteristics of guinea pig lung aromatic azaheterocycle N-methyltransferase.
      K C Cundy and P A Crooks
      Drug Metabolism and Disposition November 1985, 13 (6) 658-663;

  7. Cundy, K C

    1. In vitro characteristics of guinea pig lung aromatic azaheterocycle N-methyltransferase.
      K C Cundy and P A Crooks
      Drug Metabolism and Disposition November 1985, 13 (6) 658-663;

D

  1. Dahlqvist, R

    1. Comparison of theophylline and theobromine metabolism in man.
      D J Birkett, R Dahlqvist, J O Miners, A Lelo and B Billing
      Drug Metabolism and Disposition November 1985, 13 (6) 725-728;

  2. Dar, M S

    1. In vivo mammalian metabolism of methylamine and methylurea and their metabolic interrelationship.
      M S Dar and E R Bowman
      Drug Metabolism and Disposition November 1985, 13 (6) 682-689;

  3. Durham, S

    1. Effects of taurocholate infusion on biliary excretion in isolated perfused rat livers. Decreased biliary excretion of dibromosulfophthalein in pregnancy.
      S Durham, R Mack and M Vore
      Drug Metabolism and Disposition November 1985, 13 (6) 695-699;

E

  1. Eckerson, H W

    1. Paraoxon hydrolysis vs. covalent binding in the elimination of paraoxon in the rabbit.
      E G Butler, H W Eckerson and B N La Du
      Drug Metabolism and Disposition November 1985, 13 (6) 640-645;

G

  1. Gill, S S

    1. Age-related changes in the activities of epoxide hydrolases in different tissues of mice.
      S Kaur and S S Gill
      Drug Metabolism and Disposition November 1985, 13 (6) 711-715;

  2. Green, M D

    1. Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
      L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
      Drug Metabolism and Disposition November 1985, 13 (6) 700-704;

H

  1. Hazelton, G A

    1. Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms.
      A Rachmel, G A Hazelton, A L Yergey and D J Liberato
      Drug Metabolism and Disposition November 1985, 13 (6) 705-710;

  2. Hill, D L

    1. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
      P E Noker, D L Hill, J R Kalin, C G Temple and J A Montgomery
      Drug Metabolism and Disposition November 1985, 13 (6) 677-681;

  3. Houston, J B

    1. Quantitation of extrahepatic metabolism. Pulmonary and intestinal conjugation of naphthol.
      M Mistry and J B Houston
      Drug Metabolism and Disposition November 1985, 13 (6) 740-745;

I

  1. Inaba, T

    1. Mephenytoin hydroxylase activity in human liver: inhibition by steroids.
      M Jurima, T Inaba and W Kalow
      Drug Metabolism and Disposition November 1985, 13 (6) 746-749;

J

  1. Jurima, M

    1. Mephenytoin hydroxylase activity in human liver: inhibition by steroids.
      M Jurima, T Inaba and W Kalow
      Drug Metabolism and Disposition November 1985, 13 (6) 746-749;

K

  1. Kalin, J R

    1. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
      P E Noker, D L Hill, J R Kalin, C G Temple and J A Montgomery
      Drug Metabolism and Disposition November 1985, 13 (6) 677-681;

  2. Kalow, W

    1. Mephenytoin hydroxylase activity in human liver: inhibition by steroids.
      M Jurima, T Inaba and W Kalow
      Drug Metabolism and Disposition November 1985, 13 (6) 746-749;

  3. Kannan, R

    1. Tissue uptake and metabolism of amiodarone after chronic administration in rabbits.
      R Kannan, S Miller and B N Singh
      Drug Metabolism and Disposition November 1985, 13 (6) 646-650;

  4. Kaur, S

    1. Age-related changes in the activities of epoxide hydrolases in different tissues of mice.
      S Kaur and S S Gill
      Drug Metabolism and Disposition November 1985, 13 (6) 711-715;

  5. Keith, R A

    1. S-Methylation of D- and L-penicillamine by human erythrocyte membrane thiol methyltransferase.
      R A Keith, D M Otterness, A L Kerremans and R M Weinshilboum
      Drug Metabolism and Disposition November 1985, 13 (6) 669-676;

  6. Kerremans, A L

    1. S-Methylation of D- and L-penicillamine by human erythrocyte membrane thiol methyltransferase.
      R A Keith, D M Otterness, A L Kerremans and R M Weinshilboum
      Drug Metabolism and Disposition November 1985, 13 (6) 669-676;

  7. Kershaw, W C

    1. In vitro digitoxin metabolism. Rate-limiting step and alteration following spironolactone pretreatment.
      W C Kershaw, P Campbell and G L Lage
      Drug Metabolism and Disposition November 1985, 13 (6) 635-639;

  8. Kirkpatrick, R B

    1. Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
      L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
      Drug Metabolism and Disposition November 1985, 13 (6) 700-704;

L

  1. La Du, B N

    1. Paraoxon hydrolysis vs. covalent binding in the elimination of paraoxon in the rabbit.
      E G Butler, H W Eckerson and B N La Du
      Drug Metabolism and Disposition November 1985, 13 (6) 640-645;

  2. Lage, G L

    1. In vitro digitoxin metabolism. Rate-limiting step and alteration following spironolactone pretreatment.
      W C Kershaw, P Campbell and G L Lage
      Drug Metabolism and Disposition November 1985, 13 (6) 635-639;

  3. Lelo, A

    1. Comparison of theophylline and theobromine metabolism in man.
      D J Birkett, R Dahlqvist, J O Miners, A Lelo and B Billing
      Drug Metabolism and Disposition November 1985, 13 (6) 725-728;

  4. Liberato, D J

    1. Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate.
      M R Nocerini, G S Yost, J R Carlson, D J Liberato and R G Breeze
      Drug Metabolism and Disposition November 1985, 13 (6) 690-694;
    2. Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms.
      A Rachmel, G A Hazelton, A L Yergey and D J Liberato
      Drug Metabolism and Disposition November 1985, 13 (6) 705-710;

M

  1. Mack, R

    1. Effects of taurocholate infusion on biliary excretion in isolated perfused rat livers. Decreased biliary excretion of dibromosulfophthalein in pregnancy.
      S Durham, R Mack and M Vore
      Drug Metabolism and Disposition November 1985, 13 (6) 695-699;

  2. Miller, S

    1. Tissue uptake and metabolism of amiodarone after chronic administration in rabbits.
      R Kannan, S Miller and B N Singh
      Drug Metabolism and Disposition November 1985, 13 (6) 646-650;

  3. Minami, H

    1. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
      A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
      Drug Metabolism and Disposition November 1985, 13 (6) 729-739;

  4. Miners, J O

    1. Comparison of theophylline and theobromine metabolism in man.
      D J Birkett, R Dahlqvist, J O Miners, A Lelo and B Billing
      Drug Metabolism and Disposition November 1985, 13 (6) 725-728;

  5. Mishima, M

    1. Metabolism of strychnine in vitro.
      M Mishima, Y Tanimoto, Z Oguri and H Yoshimura
      Drug Metabolism and Disposition November 1985, 13 (6) 716-721;

  6. Mistry, M

    1. Quantitation of extrahepatic metabolism. Pulmonary and intestinal conjugation of naphthol.
      M Mistry and J B Houston
      Drug Metabolism and Disposition November 1985, 13 (6) 740-745;

  7. Montgomery, J A

    1. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
      P E Noker, D L Hill, J R Kalin, C G Temple and J A Montgomery
      Drug Metabolism and Disposition November 1985, 13 (6) 677-681;

N

  1. Nakashima, E

    1. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
      A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
      Drug Metabolism and Disposition November 1985, 13 (6) 729-739;

  2. Nishide, K

    1. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
      A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
      Drug Metabolism and Disposition November 1985, 13 (6) 729-739;

  3. Nocerini, M R

    1. Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate.
      M R Nocerini, G S Yost, J R Carlson, D J Liberato and R G Breeze
      Drug Metabolism and Disposition November 1985, 13 (6) 690-694;

  4. Noker, P E

    1. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
      P E Noker, D L Hill, J R Kalin, C G Temple and J A Montgomery
      Drug Metabolism and Disposition November 1985, 13 (6) 677-681;

O

  1. Oguri, Z

    1. Metabolism of strychnine in vitro.
      M Mishima, Y Tanimoto, Z Oguri and H Yoshimura
      Drug Metabolism and Disposition November 1985, 13 (6) 716-721;

  2. Otterness, D M

    1. S-Methylation of D- and L-penicillamine by human erythrocyte membrane thiol methyltransferase.
      R A Keith, D M Otterness, A L Kerremans and R M Weinshilboum
      Drug Metabolism and Disposition November 1985, 13 (6) 669-676;

R

  1. Rachmel, A

    1. Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms.
      A Rachmel, G A Hazelton, A L Yergey and D J Liberato
      Drug Metabolism and Disposition November 1985, 13 (6) 705-710;

  2. Rickert, D E

    1. Isomer- and sex-specific bioactivation of mononitrotoluenes. Role of enterohepatic circulation.
      J P Chism and D E Rickert
      Drug Metabolism and Disposition November 1985, 13 (6) 651-657;
    2. Metabolism of dinitrobenzenes by rat isolated hepatocytes.
      P A Cossum and D E Rickert
      Drug Metabolism and Disposition November 1985, 13 (6) 664-668;

S

  1. Schmoldt, A

    1. Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
      L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
      Drug Metabolism and Disposition November 1985, 13 (6) 700-704;

  2. Singh, B N

    1. Tissue uptake and metabolism of amiodarone after chronic administration in rabbits.
      R Kannan, S Miller and B N Singh
      Drug Metabolism and Disposition November 1985, 13 (6) 646-650;

  3. Soulinna, E M

    1. 7-Ethoxycoumarin O-deethylation and methylumbelliferone conjugation in isolated fetal and adult bovine hepatocytes.
      E M Soulinna and A M Winberg
      Drug Metabolism and Disposition November 1985, 13 (6) 722-724;

T

  1. Tanimoto, Y

    1. Metabolism of strychnine in vitro.
      M Mishima, Y Tanimoto, Z Oguri and H Yoshimura
      Drug Metabolism and Disposition November 1985, 13 (6) 716-721;

  2. Temple, C G

    1. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
      P E Noker, D L Hill, J R Kalin, C G Temple and J A Montgomery
      Drug Metabolism and Disposition November 1985, 13 (6) 677-681;

  3. Tephly, T R

    1. Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
      L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
      Drug Metabolism and Disposition November 1985, 13 (6) 700-704;

  4. Terasaki, T

    1. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
      A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
      Drug Metabolism and Disposition November 1985, 13 (6) 729-739;

  5. Tsuji, A

    1. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
      A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
      Drug Metabolism and Disposition November 1985, 13 (6) 729-739;

V

  1. von Meyerinck, L

    1. Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
      L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
      Drug Metabolism and Disposition November 1985, 13 (6) 700-704;

  2. Vore, M

    1. Effects of taurocholate infusion on biliary excretion in isolated perfused rat livers. Decreased biliary excretion of dibromosulfophthalein in pregnancy.
      S Durham, R Mack and M Vore
      Drug Metabolism and Disposition November 1985, 13 (6) 695-699;

W

  1. Weinshilboum, R M

    1. S-Methylation of D- and L-penicillamine by human erythrocyte membrane thiol methyltransferase.
      R A Keith, D M Otterness, A L Kerremans and R M Weinshilboum
      Drug Metabolism and Disposition November 1985, 13 (6) 669-676;

  2. Winberg, A M

    1. 7-Ethoxycoumarin O-deethylation and methylumbelliferone conjugation in isolated fetal and adult bovine hepatocytes.
      E M Soulinna and A M Winberg
      Drug Metabolism and Disposition November 1985, 13 (6) 722-724;

Y

  1. Yamana, T

    1. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
      A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
      Drug Metabolism and Disposition November 1985, 13 (6) 729-739;

  2. Yergey, A L

    1. Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms.
      A Rachmel, G A Hazelton, A L Yergey and D J Liberato
      Drug Metabolism and Disposition November 1985, 13 (6) 705-710;

  3. Yoshimura, H

    1. Metabolism of strychnine in vitro.
      M Mishima, Y Tanimoto, Z Oguri and H Yoshimura
      Drug Metabolism and Disposition November 1985, 13 (6) 716-721;

  4. Yost, G S

    1. Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate.
      M R Nocerini, G S Yost, J R Carlson, D J Liberato and R G Breeze
      Drug Metabolism and Disposition November 1985, 13 (6) 690-694;
Back to top

In this issue

Advertisement